Quiet Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Liquidation

Quiet Therapeutics General Information

Description

Developer of cancer drugs designed to specifically target tumor cells. The company's drugs utilize its proprietary GAGomer technology that target the specific cancer cells, that leads to the death of the cancer cells, enabling healthcare providers to cure their patients and improve their lives.

Contact Information

Website
www.quietx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 18 Einstein Street, 5th floor
  • POB: 4053
  • Ness Ziona 74140
  • Israel
+972
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 18 Einstein Street, 5th floor
  • POB: 4053
  • Ness Ziona 74140
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quiet Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 01-Jan-2017 Completed Out of Business
3. Later Stage VC 01-Apr-2015 Completed Startup
2. Grant 01-Nov-2013 $2.86M $5.5M Completed Startup
1. Early Stage VC 15-Jan-2013 $5.5M $5.5M Completed Startup
To view Quiet Therapeutics’s complete valuation and funding history, request access »

Quiet Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer drugs designed to specifically target tumor cells. The company's drugs utilize its proprietary GAGom
Drug Delivery
Ness Ziona, Israel
4 As of 2014

Basel, Switzerland
 

Edinburgh, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quiet Therapeutics Competitors (51)

One of Quiet Therapeutics’s 51 competitors is TOLREMO therapeutics, a Venture Capital-Backed company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TOLREMO therapeutics Venture Capital-Backed Basel, Switzerland
Macomics Venture Capital-Backed Edinburgh, United Kingdom
CV6 Therapeutics Venture Capital-Backed Belfast, United Kingdom
T3 Pharmaceuticals Formerly VC-backed Allschwil, Switzerland
Meditope Biosciences Venture Capital-Backed Pasadena, CA
You’re viewing 5 of 51 competitors. Get the full list »

Quiet Therapeutics Patents

Quiet Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2013250767-A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids Inactive 18-Apr-2012
CA-2868238-A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids Inactive 18-Apr-2012
EP-2839015-A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids Active 18-Apr-2012
EP-2839015-B1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids Inactive 18-Apr-2012 A61K9/16

Quiet Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quiet Therapeutics FAQs

  • When was Quiet Therapeutics founded?

    Quiet Therapeutics was founded in 2010.

  • Where is Quiet Therapeutics headquartered?

    Quiet Therapeutics is headquartered in Ness Ziona, Israel.

  • What is the size of Quiet Therapeutics?

    Quiet Therapeutics has 4 total employees.

  • What industry is Quiet Therapeutics in?

    Quiet Therapeutics’s primary industry is Drug Delivery.

  • Is Quiet Therapeutics a private or public company?

    Quiet Therapeutics is a Private company.

  • What is Quiet Therapeutics’s current revenue?

    The current revenue for Quiet Therapeutics is .

  • How much funding has Quiet Therapeutics raised over time?

    Quiet Therapeutics has raised $17.5M.

  • Who are Quiet Therapeutics’s competitors?

    TOLREMO therapeutics, Macomics, CV6 Therapeutics, T3 Pharmaceuticals, and Meditope Biosciences are some of the 51 competitors of Quiet Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »